Molecular mechanisms of toxic effects of fotemustine in rat hepatocytes and subcellular rat liver fractions

Carcinogenesis

Volumn 17, Issue 4, 1996, Pages 715-724

  Brakenhoff, Jan P G ^a   Commandeur, Jan N M ^a   Wonnhoudt, Lars W ^a   Groot, Ed J ^a   Vermeulen, Nico P E ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; DRUG METABOLITE; FOTEMUSTINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; LIPID PEROXIDATION; LIVER CELL; LIVER MICROSOME; LIVER TOXICITY; MALE; NONHUMAN; PEROXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CATALASE; CYTOSOL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; KINETICS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LIVER; NITROSOUREA COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; RATS; SUBCELLULAR FRACTIONS; SUPEROXIDE DISMUTASE;

EID: 0029877012     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.4.715     Document Type: Article

References (55)

1. Fichel,J.L., Formento,P and Etienne.M.C (1990) In vitro chemosensitivity testing of fotemustine (S10036), a new antitumor nitrosourea. Cancer Chem. Pharmacol., 25, 727-729.
2. Bizzari,J.-P. and Deloffre,P. (1988) Pharmacocinetique clinique des nitrosourees. Bull. Cancer. 75, 813-818.
3. Jacquillat,C., Khayat,D., Banzet,P. et al. (1990) Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasis. Cancer, 66, 1873-1878.
4. Patterson,R., Nugent,K,M., Harris,K.E. and Eberle,M.E. (1990) Immunologic hemorrhagic pneumonia caused by isocyanates. Am. Rev. Resp. Dis., 141, 226-230.
5. Kramer, R.A., Boyd, M.R. and Dees, J.H. (1986) Comparasive nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) and chlorozotocin: functional-structural correlations in the Fischer 344 rat. Toxicol. Appl. Pharmacol., 82, 540-550.
6. Babson,J., Reed,D. J. and Sinkey,M.A. (1977) Active site specifc inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyI)-1-nitrosourea. Biochemistry, 16, 1584-4589.
7. Jeevaatnam,K. and Vaidyanathan,C.S. (1992) Acute toxicity of methyl tsocyanate in rabbit: in vtiro and in vivo effects on rabbit erythrocyte membrane Arch, Environ. Toxicol., 22, 300-304.
8. Babson,J.R. and Reed,D.J. (1978) Inactivation of glutathione reductase by 2-chloroethylnitrosourea-derived isocyanates. Biochem. Biophys. Res. Commun., 83, 754-762.
9. Lee,M.-S. (1992) Oxidative conversion by rat liver microsomes of 2-naphthyl isothiocyanate to 2-naphthyl isocyanate, a genotoxicant. Chem. Res Toxicol., 5, 791-796.
10. Nemery,B , Dinsdale,D., Sparrow,S. and Ray,D.E. (1985) Effects of methyl isocyanate on the respiratory tract of rats. Br. J. Ind. Med., 42, 799-805.
11. Karol,M.H. and Jin,R. (1991) Mechanisms of immunotoxicity to isocyanates. Chem. Res Toxicol, 4, 503-509.
12. Pauluhn,J. and Eben,A, (1992) Altered lung function in rats after subacute exposure to n-butyl isocyanate. Arch. Toxicol., 66, 118-125.
13. Gerard,B., Aamdal,S., Lee,S.-M., Leyvraz,S., Lucas,C., D'Incalci,M. and Bizzari,J.P (1993) Activity and unexpected lungtoxicity of the sequential administration of two alkylating agents-dacarbazine and fotemustine-in patients with melanoma. Eur. J. Cancer, 29, 711-719.
14. Eisenbrand,G. and Habs,M. (1980) Chronic toxicity of cytostatic N-nitroso(2-chloroethyl)-ureas after repeated intraveneous application in rats. In Holmstedt et al. (eds), Mechanisms of toxicity and hazard evaluation, pp. 273-278.
15. Boutin,J.A., Norbreck,K., Moldeus,P., Genton,A., Paraire,M., Bizzari,J.P., Lavielle,G. and Cudennec,C.A. (1989) Effects of the new nitrosourea derivative fotemustine on the glutathione reductase activity in rat tissues in vivo and in isolated rat hepatocytes. Eur J. Cancer Clin. Oncol., 25, 1311-1316.
16. Schallreuter,K.U., Gleason,FK. and Wood,J.M. (1990) The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and nbonucleotide reductase. Btochtm. Biophys. Acta. 1054, 14-20.
17. Brakenhoff,J.P.G., Commandeur,J.N.M., de Kanter,F.J.J., van Baar,B.L.M., Luijten,W.C.M.M. and Vermeulen,N.P.E. (1994) Chemical and glutathione conjugation-related degradation of fotemustine: formation and characterization of a glutathione conjugate of diethyl(1-isocyanatoethyl) phosphorate a reactive metabolite of fotemustine. Chem. Res. Toxicol., 7, 380-389.
18. Brakenhoff,J.P.G., Commandeur,J.N.M., Lamorée,M.H., Dubelaar,A.C., van Baar,B.L.M., Lucas,C. and Vermeulen,N.P.E. (1993) Identification and quantitative determination of glutathione-related urinary metabolites of fotemustine, a new anti-cancer agent. Xenobiotica, 23, 935-947.
19. Slatter,J.G., Davis,M.R., Han,D-H., Pearson,P.G. and Baillie,T.A. (1993) Studies on the metabolic fate of caracemide, an experimental antitumor agent in the rat. Evidence for the release of methyl isocyanate in vivo. Chem. Res. Toxicol., 6, 335-340.
20. Stahl,W., Lenhardt,S., Przybylski,M. and Eisenbrand,G. (1992) Mechanism of glutathione-mediated DNA damage by the antineoplastic agent 1,3-bis(2-chloroethyl)-N-nitrosourea Chem. Res. Toxtcol., 5, 106-109.
21. Stahl,W. (1987) Untersuchungen zur reaction von 2-chloroethylnitrosohamstoffen doctoral thesis, department of food chemistry and environmental toxicology, Kaiserslautern, Germany.
22. Jefcoate,C.R. (1978) Measurement of substrate and inhibitor binding to microsonal cytochrome P450. Method Enzymol, 52, 258-279.
23. Sazuka,Y., Tanizawa,H. and Takino,Y. (1989) Effect of adriamycin on the activities of Superoxide dismutase, glutathione peroxidase and catalase in tissues of mice. Jpn J. Cancer. Res., 80, 89-94
24. Paglia,D.E. and Valentine,W.N. (1967) Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab. Clin. Med., 70, 158-169.
25. Worthington,D.J. and Rosemeyer,M.A. (1974) Purification of the crystalline enzyme from erythrocytes. Eur. J. Biochem., 48, 167-177.
26. Habig,W.H., Pabst,M.J. and Jacoby,W.B (1974) The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
27. Haenen,G.R.M.M., Vermeulen,NP.E., Timmerman,H. and Bast,A. (1989) Effects of thiols on lipid peroxidation in rat liver microsomes. Chem. Biol Interactions, 71, 201-212.
28. Nagelkerke,J.F., Barto,K.P. and van Berkel,T.J.C. (1983) J. Biol. Chem., 258, 12221-12227.
29. van de Straat,R., de Vries,J., Debets,A.J.J. and Vermeulen,N.P.E. (1987) Biochem. Pharmacol., 36, 2065-2070.
30. Redegeld,F.A.M., van Opstal,M.A.J., Houdkamp,E. and van Bennekom,W.P. (1988) Determination of glutathione in biological material by flow-injection analysis using an enzyme recycling reaction. Analyt. Biochem., 174, 489-495
31. Bruggeman,I.M., TemminkJ,H.M. and van Bladeren,P.J. (1986) Glutathione- and cysteine-mediated cytotoxicity of allyl and benzyl isothiocyanate. Toxicol. Appl Pharmacol, 83, 349-359.
32. Slatter,J.G., Rashed,M.S., Pearson,P.G., Han,D.-H. and Baillie,T.A. (1991) Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities. Chem. Res. Toxicol., 4, 157-161.
33. Cerami,A. and Manning,J.M. (1971) Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro. Proc. Natl Acad. Sci. USA, 68, 1180-1183.
34. Comporti,M. (1989) Three models of free radical-induced cell injury. Chem. -Biol. Interactions, 72, 1-56.
35. Comporti,M. (1987) Glutathione depleting agents and lipid peroxidation. Chem. Phys. Lipids, 45, 143-169.
36. Bast,A. and Haenen,G.R.M.M. (1984) Cytochrome P-450 and glutathione, what is the significance of their interrelationship in lipid peroxidation. Trends Biochem. Sci, 9, 510-513.
37. 2+ aequestration during oxidative stress and its revention against glutathione. J. Biol. Chem., 258, 6390-6393.
38. 2+ homeostasis. Arch. Biochem. Biophys., 235, 343-350.
39. 2+ sequestration by the plasma membrane fraction from the rat liver. FEBS Lett., 163, 136-139.
40. 2+ sequestration by toxic agents. Biochem,. Pharmacol., 34, 3717-3723.
41. Bast,A., Leurs,R. and Timmerman,H. (1989) Cyclandelate as a calcium modulating agent in rat cerebral cortex. Drugs, 33, 67-74.
42. Prohaska,J.R. (1980) The glutathione peroxidase activity of the glutathione-S-transferases. Biochim. Biophys. Acta. 611, 157-174.
43. Khayat,D., Lokiec.F., Bizzari,J.P., Weil,M., Meeus,L., Sellami,M., Rouesse,J., Banzet,P. and Jacquillat,C. (1987) Phase I clinical study of the amino acid-linked nitrosourea, S 10036, administered on a weekly schedule. Cancer Res., 47, 6782-6785.
44. Commandeur,J.N.M., Stijntjes,G.J. and Vermeulen,N.P.E. (1995) Enzymes and transport systems involved in the formation and dispostion of glutathione-S-conjugates. Pharmacol. Rev., 47. 271-336.
45. Jochheim,C.M. and Baillie,T.A. (1994) Selective and irreversible inhibition of glutathione reductase in vitro by carbamate thioester conjugates of methyl isocyanate. Biochem. Pharmacol.. 48, 1197.
46. Kassahun,A. et al. (1994) Effects of carabamate thioester derivatives of methyl and 2-chloroelhyl isocyanate on glutathione levels and glutathione reductase activities in tha rat. Biochem. Pharmacol., 48, 587.
47. Shinohara,K. and Tanaka,K.R. (1979) Mechanism of inhibition of red blood cell glutathione reductase activity by BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea). Clin. Chim. Acta, 92, 147-152.
48. Stahl,W. and Eisenbrand,G. (1991) Comparative study on the influence of two 2-chloroethylnitrosoureas with different carbamoylating potential towards glutathione and glutathione related enzyms in different organs in the rat. Free Rod. Res. Commun., 14, 271-278.
49. Kann,H.E. (1981) Carbamoylating activity of nitrosoureas. In Prestakyo,A.W. et al (eds), Nitrosoureas: current status and new developements. Academic Press. New York, pp. 95-105.
50. Ali-Osman,F., Ginlin,J., Berger,M., Murphy,M. and Rosenblum,M. (1985) Chemical structure of carbamoylating groups and their relationships to bone marrow toxicity and antiglioma activity of bifunctional alkylating and carbamoylating agents. Cancer Res., 45. 4185-4191.
51. Karplus,P.A., Krauth-Siegel,R.L., Schirmer,R.H. and Schultz,G.E. (1988) Inhibition of human glutattuone reductase by the nitrosourea drugs 1.3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. Eur. J .Biochem., 171. 193-198.
52. Tew,K.D., Dean,S.W. and Gibson,N.W. (1987) The effect of a novel taurine nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosourea (TCNU) on cytotoxicity, DNA crosslinking and glutathione reductase in lung carcinoma cell lines. Cancer Chem. Pharmacol., 19, 291-295.
53. Jeevaratnam,K., Vidya,S. and Vaidyanathan,C.S. (1993) Role of lipid peroxidauon in impairment of mitochondrial function at complex I by methylisocyanate treatment of rats in vivo. Biochem. Mol. Biol. Int., 30, 411-417.
54. Meredith,M.J. and Reed,D.J. (1983) Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Biochem. Pharmacol., 32, 1383-1388.
55. Vermeulen,N.P.E., den Kelder,D.-O. and Commandeur,J.K.M. (1993) Formation and protection against toxic reactive intermediates. In Tesla,B., Kyburz,E., Fuhrer,W. and Giger,R. (eds), Perspectives in medicinal chemisiry. Verlag Helvetica Chimica Acta, Basel, Switzerland, pp. 573-593.